Skip to main content
FinSpry Logo
FinSpry
ALT logo
ALT
(NASDAQ)
Altimmune, Inc.
$2.82-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Altimmune (ALT) Stock Price & Financial Analysis

Altimmune Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.73 - $2.84
52-Week High$7.73
52-Week Low$2.56
Open$2.80
Volume2.51M
Average Volume (3M)4.52M
Market Cap246.69M
Shares Outstanding88.10M
Price to Sales (P/S)6124.31
Price to Book (P/B)1.12
EV/EBITDA-2.63
Revenue (TTM)41.00K
Net Income (TTM)-88.09M
Free Cash Flow (TTM)-67.55M
EPS (TTM)$-1.02
Profit Margin-214860.98%
Operating Margin-230460.98%
Return on Equity (ROE)-39.17%
Debt to Equity0.15
50-Day MA$3.30
200-Day MA$3.99
52-Week Change-48.59%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateFeb 6, 2017

Frequently Asked Questions About Altimmune

What is the current stock price for ALT?

As of the latest trading session, ALT stock trades at $2.74. The 52-week range is $2.56–$7.73, with a day range of $2.73–$2.84.

What is the P/E ratio for ALT?

The P/E ratio (Price-to-Earnings) for ALT is shown in the Key Statistics section. This valuation metric helps compare Altimmune, Inc. to industry peers.

Does ALT pay dividends?

Altimmune does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ALT?

Based on 4 analysts, the consensus for ALT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ALT?

Altimmune's market capitalization is $241.4M, classifying it as a micro-cap company..